New Drugs

Gelesis Granted FDA Clearance to Market Plenity – a New Prescription Aid in Weight Management

Written by David Miller

BOSTON, April 14, 2019 — Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, today announced that the United States Food and…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]